Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Number of patients suffering from class-specific side effects during the respective BRAF+MEK inhibitor combination (vemurafenib + cobimetinib [V+C], dabrafenib + trametinib [D+T], or encorafenib + binimetinib [E+B]). Numbers in arrows represent the number of patients who experienced the same side effect during the second BRAFi+MEKi combination as well (e.g., 0/7 patients with a rash during V+C also experienced a rash during D+T).
